| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 01/07/2026 | |
Jinchul Jeong
DFI | Director of Finance/CFO | - | - |
Greg Oehrtman
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Bailey
BRD | Director/Board Member | 60 | 30/06/2026 |
| Director/Board Member | - | 01/07/2026 | |
Jinchul Jeong
BRD | Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/19/23 A | Issuer sale | Director | 110,043 | 0.3166% | ||
| 1/19/23 A | Issuer sale | Chief Financial Officer | 368,800 | 1.0609% | ||
| 1/19/23 A | Issuer sale | Director | 49,000 | 0.1410% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +0.20% | - | - | 521M | |
| +2.99% | +0.53% | +20.96% | -9.26% | 66.74B | |
| -0.08% | +3.28% | +37.43% | +203.98% | 53.32B | |
| +1.78% | +54.50% | +54.50% | +54.50% | 48.12B | |
| +1.90% | -5.62% | -56.56% | -55.72% | 38.25B | |
| +0.09% | +1.22% | +56.55% | -22.98% | 29.85B | |
| +1.31% | +3.15% | +70.03% | +90.32% | 23.51B | |
| +3.46% | -6.49% | +64.05% | -53.06% | 21.45B | |
| +0.57% | +4.16% | +81.96% | +161.81% | 16.47B | |
| +1.44% | +0.22% | +64.66% | +126.78% | 16.38B | |
| Average | +1.40% | -0.96% | +43.73% | +55.15% | 34.9B | |
| Weighted average by Cap. | +1.64% | -0.31% | +34.93% | +50.27% |
Employees
114
Sector
Pharmaceuticals
